SCHEMBL2489138

SCHEMBL2489138

COc1ccc(-c2cccc(COCCN)c2-c2ccc(OC)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.40
ABL1 P00519 1/20 0.40
ABCB1 P08183 1/20 0.40
BCR P11274 1/20 0.40
HDAC4 P56524 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
CD274 Q9NZQ7 1/20 0.39
FFAR1 O14842 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ATM Q13315 1/20 0.37
ENPP1 P22413 1/20 0.37
SYK P43405 4/20 0.36
AURKB Q96GD4 1/20 0.36
INCENP Q9NQS7 1/20 0.36
BACE1 P56817 1/20 0.36
HEXA P06865 1/20 0.36
HEXB P07686 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL430965 0.88 ABL1 (0.46) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL2495694 0.87 HDAC4 (0.43) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL2489493 0.77 HDAC4 (0.50) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL1974122 0.76 ABL1 (0.46) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL7024625 0.76 ABL1 (0.46) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL9959026 0.76 ABL1 (0.46) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL2495623 0.74 TAAR1 (0.46) CD274RAB9ATAAR1HTR7
SCHEMBL2357517 0.74 ESR2 (0.41) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL6894911 0.74 MAPT (0.37) HDAC4HDAC2HDAC8FFAR1FFAR4
SCHEMBL6411289 0.73 FFAR1 (0.38) CD274FFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH MAOB 30/4885ABL1 220/4885ABCB1 1592/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 MAOB 29/4885ABL1 289/4885ABCB1 1287/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R MAOB 34/4885ABL1 275/4885ABCB1 1331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.